Mandolin

Mandolin

AI-driven automation for specialty drug access

Overview

Mandolin provides an AI-driven automation platform for the specialty pharmaceutical market. Its system uses AI agents that act as a digital workforce and plug into existing EHRs, payer portals, and manufacturer hubs to handle back-office tasks for infused and injected drugs. These agents automate steps like benefits verification, insurance navigation, prior authorizations, parsing documents, and billing to manage the patient access workflow from referral to reimbursement. The platform targets infusion centers, specialty pharmacies, and health systems, aiming to shorten delays to treatment, reduce operating costs, and improve revenue cycle management.

Significant Headcount Growth

About Mandolin

Simplify's Rating
Why Mandolin is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

11-50

Company Stage

Series A

Total Funding

$40M

Headquarters

San Francisco, California

Founded

2024

Get referred to Mandolin

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 2025 funding from Greylock and SignalFire gives Mandolin capital for aggressive hiring.
  • June 2026-2026 blog posts signal active product velocity and constant workflow expansion.
  • Customer claims of 24x faster processing and under-two-hour turnaround support budget justification.

What critics are saying

  • CoverMyMeds, Waystar, Rhyme, and Availity attack adjacent workflows; buyers already have defaults.
  • Healthcare AI agents face hallucination, audit, and denial risk when payer rules change.
  • If one large customer churns after 2025 pilots, Mandolin's specialty-drug platform loses credibility fast.

What makes Mandolin unique

  • 2025 product automates specialty-drug intake through reimbursement across 700 clinic locations.
  • Mandolin integrates with EHRs, payer portals, and manufacturer hubs for end-to-end workflow control.
  • Will Yin and Rohit Rustagi bring repeat-founder credibility and a rare specialty-drug focus.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$40M

Above

Industry Average

Funded Over

2 Rounds

Notable Investors:
Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Above Average

Industry standards

$15M
$8.2M
Discord
$15M
Canva
$30M
Kalshi
$32M
Mandolin

Benefits

Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

↑ 11%

1 year growth

↑ 11%

2 year growth

↑ 11%
Mandolin
Sep 20th, 2026
$40 Million to Obliterate Specialty Drug Paperwork

Jul 13, 2026 | Fueling Mandolin’s next chapter of hyper-growth — and the engineering breakthroughs that power it.

Business Wire
Jun 26th, 2025
Mandolin Raises $40M to Improve Access to Life-Saving Therapies for Diseases like Cancer and Alzheimer's Using AI Agents

Mandolin, the leading AI automation platform for specialty drug access, announced that it has raised $40 million in funding from Greylock Partners, SignalFir...

FinSMEs
Jun 26th, 2025
Mandolin Raises $40M in Funding

Mandolin raises $40M in funding.

MarketScreener
Jun 25th, 2025
Mandolin raises $40M for insurance tech

Health-care companies saw gains as traders turned to defensive sectors amid geopolitical and inflation concerns. Mandolin, a startup aiding health-care providers in verifying insurance coverage for specialty drugs, secured $40 million in seed and Series A funding.

Recently Posted Jobs

Sign up to get curated job recommendations

Mandolin is Hiring for 5 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →